Danish pharmaceutical company Novo Nordisk stated in connection with the report presentation that sales growth in 2025 could be "high teens" in percentage terms. This means a high figure in the range of 13-19 percent.

"This is a forward-looking statement, mathematically based, and we will come back with more detailed guidance in early February 2025," said CFO Karsten Munk Knudsen.

Novo Nordisk rose sharply in early morning trading but has fallen back. Just after 14.30 on Wednesday, the share is up 2.6 percent.